S22N (p.Ser22Asn) variant of TAFAZZIN (Q16635)
S22N (p.Ser22Asn) in TAFAZZIN (Q16635) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
S22N (p.Ser22Asn) variant details
- p.Ser22Asn
- NCI-TCGA Cosmic COSV5001
- cosmic curated COSV50010
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available